Related Experiment Video

Updated: May 21, 2026

Identification of Mediators of T-cell Receptor Signaling via the Screening of Chemical Inhibitor Libraries
08:49

Identification of Mediators of T-cell Receptor Signaling via the Screening of Chemical Inhibitor Libraries

Published on: January 22, 2019

Multiple signal transduction pathways are involved in G2/M growth arrest and apoptosis induced by the immunomodulator

Yaniv Naor1, Michal Hayun, Benjamin Sredni

  • 1Safdié Institute for AIDS and Immunology Research, The Mina & Everard Goodman Faculty of Life Sciences, Bar-Ilan University, Ramat-Gan, Israel.

Leukemia & Lymphoma
|June 21, 2012
PubMed

Insights

The organotellurium compound AS101 triggers cell death and growth arrest in multiple myeloma (MM) by affecting key cell cycle proteins and signaling pathways. This multifaceted mechanism suggests AS101

Area of Science:

  • Oncology
  • Pharmacology
  • Molecular Biology

Background:

  • Multiple myeloma (MM) is a hematological malignancy characterized by uncontrolled plasma cell proliferation.
  • Organotellurium compounds, such as AS101, have shown potential anti-cancer properties.
  • Understanding the molecular mechanisms of AS101 is crucial for its therapeutic development in MM.

Purpose of the Study:

  • To elucidate the molecular mechanisms by which AS101 induces G(2)/M growth arrest and apoptosis in multiple myeloma cells.
  • To identify specific protein and phosphoprotein targets affected by AS101 treatment.

Main Methods:

  • Antibody microarray analysis was employed to compare protein and phosphoprotein levels.
  • Mouse 5T33 MM cells were treated with AS101 and compared to untreated controls.
  • Key signaling molecules involved in cell cycle regulation and survival were quantified.

Main Results:

  • AS101 down-regulated ILK-1, Cdc25C, and phosphorylation of PLK-1 (Threonine 210), impacting mitosis and cell survival.
  • AS101 inhibited the activity of the MMP-9/NGAL complex, a matrix metalloproteinase.
  • AS101 treatment led to elevated levels of p53 and p65/RelA, indicating modulation of these critical signaling proteins.

Conclusions:

  • AS101 induces G(2)/M growth arrest and apoptosis in multiple myeloma through the modulation of multiple signaling pathways.
  • The drug affects cell cycle regulators (ILK-1, Cdc25C, PLK-1) and matrix metalloproteinases (MMP-9/NGAL).
  • Activation of p53 and p65/RelA pathways by AS101 suggests a robust anti-myeloma effect, potentially overcoming resistance through alternative pathways.

More Related Videos

Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants07:38

Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants

Published on: June 6, 2025

Real Time Detection of In Vitro Tumor Cell Apoptosis Induced by CD8+ T Cells to Study Immune Suppressive Functions of Tumor-infiltrating Myeloid Cells09:57

Real Time Detection of In Vitro Tumor Cell Apoptosis Induced by CD8+ T Cells to Study Immune Suppressive Functions of Tumor-infiltrating Myeloid Cells

Published on: January 29, 2019

Related Concept Videos

Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Amplifying Signals via Enzymatic Cascade01:22

Amplifying Signals via Enzymatic Cascade

When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze the...
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...